IRCT2016100716876N2已完成未知
Resveratrol's Effects in Diabetic Nephropathy
Vice chancellor for research,shiraz university of medical sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •Type 2 diabetes mellitus (DM)
- •Controlled blood sugar [fasting blood sugar (FBS) <130mg/dl and glycosylated
- •hemoglobin (A1C)<7%
- •Urine albumin >20mg/lit in two separate occasions during the last 3 months period
- •Serum creatinin < or = 2mg/dl
排除标准
- •Pregnancy
- •Lactation
- •Alcoholism
- •Liver failure (acute or chronic)
- •Renal failure: serum creatinin >2mg/dl
- •Glomerulonephritis
- •Uncontrolled hypertension
- •Congestive heart failure
- •Prostate disease
- •Malignancy
- •Bilateral renal artery stenosis
- •Any systemic disease other than DM
- •Any infection or rheumatologic disorder
- •Use of warfarin
研究者
相似试验
已完成
早期 1 期
Resveratrol's Effects in Diabetic NephropathyDiabetic NephropathyNCT02704494Shiraz University of Medical Sciences60
已完成
不适用
odular Lesions in Diabetic Nephropathy: collagen staining and renal prognosisDiabetic nephropathyJPRN-UMIN000017871Toranomon Hospital50
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
尚未招募
3 期
Resveratrol in acute ischemic strokeAcute ischemic stroke.Cerebral infarction, unspecifiedI63.9IRCT20091114002709N61Iran University of Medical Sciences76